Randomised clinical trial: Evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation - A placebo-controlled study

Alimentary Pharmacology and Therapeutics

Volumn 38, Issue 3, 2013, Pages 264-273

  Watanabe, M ^a   Nishino, H ^b   Sameshima, Y ^c   Ota, A ^d   Nakamura, S ^e   Hibi, T ^f  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Colo Proctology Center Matsushima Clinic ^*  (Japan)

^c Sameshima Hospital   (Japan)

^d Ieda Hospital   (Japan)

^e HYOGO COLLEGE OF MEDICINE   (Japan)

^f KEIO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; PLACEBO;

ADOLESCENT; ADULT; AGED; ARTICLE; COLON HEMORRHAGE; COLONOSCOPY; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARALLEL DESIGN; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECTAL INFLAMMATION; RECTUM DISEASE; REMISSION; RHINOPHARYNGITIS; SCORING SYSTEM; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASIAN CONTINENTAL ANCESTRY GROUP; COLITIS, ULCERATIVE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; MALE; MESALAMINE; MIDDLE AGED; PROCTITIS; SUPPOSITORIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879786241     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12362     Document Type: Article

References (18)

1. Kornbluth A, Sachar DB,. UC practice guidelines in adults: American college of gastroenterology, practice parameters committee. Am J Gastroenterol 2010; 105: 501-23.
2. Dignass A, Lindsay JO, Sturm A, et al,. Second European evidence-based consensus on the diagnosis and management of UC: current management. J Crohns Colitis 2012; 6: 991-1030.
3. Langholz E, Munkholm P, Davidsen M, Nielsen OH, Binder V,. Changes in extent of UC: a study on the course and prognostic factors. Scand J Gastroenterol 1996; 31: 260-6.
4. Ayres RC, Gillen CD, Walmsley RS, Allan RN,. Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression. Eur J Gastroenterol Hepatol 1996; 8: 555-8.
5. Henriksen M, Jahnsen J, Lygren I, et al,. UC and clinical course: results of a 5-year population-based follow-up study (the IBSEN study). Inflamm Bowel Dis 2006; 12: 543-50.
6. Williams CN, Haber G, Aquino JA,. Double-blind, placebo-controlled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using 99mTc-labeled 5-ASA suppositories. Dig Dis Sci 1987; 32: 71S-5S.
7. van Hogezand RA, van Hees PA, van Gorp JP, et al,. Double-blind comparison of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid suppositories in patients with idiopathic proctitis. Aliment Pharmacol Ther 1988; 2: 33-40.
8. Williams CN,. Efficacy and tolerance of 5-aminosalicylic acid suppositories in the treatment of ulcerative proctitis: a review of two double-blind, placebo controlled trials. Can J Gastroenterol 1990; 4: 472-5.
9. Campieri M, Gionchetti P, Belluzzi A, et al,. Topical treatment with 5-aminosalicylic in distal UC by using a new suppository preparation. A double-blind placebo controlled trial. Int J Colorectal Dis 1990; 5: 79-81.
10. Campieri M, De Franchis R, Bianchi Porro G, et al,. Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial. Scand J Gastroenterol 1990; 25: 663-8.
11. Ngô Y, Gélinet JM, Ivanovic A, et al,. Efficacy of a daily application of mesalazine (Pentasa) suppository with progressive release, in the treatment of ulcerative proctitis. A double-blind versus placebo randomized trial. Gastroenterol Clin Biol 1992; 16: 782-6.
12. Gionchetti P, Rizzello F, Venturi A, et al,. Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis. Dis Colon Rectum 1998; 41: 93-7.
13. Sutherland LR, Martin F, Greer S, et al,. 5-Aminosalicylic acid enema in the treatment of distal UC, proctosigmoiditis, and proctitis. Gastroenterology 1987; 92: 1894-8.
14. Schroeder KW, Tremaine WJ, Ilstrup DM,. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active UC. A randomized study. N Engl J Med 1987; 317: 1625-9.
15. Lucidarme D, Marteau P, Foucault M,. Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis. Aliment Pharmacol Ther 1997; 11: 335-40.
16. Langholz E, Munkholm P, Davidsen MN, et al,. Changes in extent of UC. Scand J Gastroenterol 1996; 31: 260-6.
17. Ayres RC, Gillen CD, Walmsley RS, et al,. Progression of ulcerative proctosigmoiditis: incidence and factors influencing progression. Eur J Gastroenterol Hepatol 1996; 8: 555-8.
18. Henriksen M, Jahnsen J, Lygren I, et al,. UC and clinical course: results of a 5-year population-based followed-up study (The IBSEN Study). Inflamm Bowel Dis 2006; 12: 543-50.